Welcome to our dedicated page for Crown Castle SEC filings (Ticker: CCI), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Depreciation schedules, lease escalation clauses, and fiber capex tables can make Crown Castle鈥檚 disclosures feel like an engineering manual. If you have ever searched for Crown Castle SEC filings explained simply, you already know the challenge: hundreds of pages separating you from answers on tenancy rates, carrier concentration, or dividend safety.
Stock Titan solves that problem. Our AI reads every Crown Castle annual report 10-K simplified, flags tower-versus-fiber revenue, and highlights cash-flow metrics in seconds. New documents flow straight from EDGAR, so your dashboard shows Crown Castle Form 4 insider transactions real-time, the latest Crown Castle quarterly earnings report 10-Q filing, and each Crown Castle 8-K material events explained without delay. Want to track management trades? We surface Crown Castle insider trading Form 4 transactions alongside charts comparing option grants to share price moves. Comparing periods is just as direct: AI links footnotes so your Crown Castle earnings report filing analysis takes minutes, not hours.
Because the company operates as a REIT, its proxy reveals how AFFO drives bonuses. Use our platform to parse every Crown Castle proxy statement executive compensation table or investigate a sudden cluster of Crown Castle executive stock transactions Form 4. Prefer narrative? Our plain-English summaries let you focus on themes鈥�5G small-cell rollouts, fiber monetisation, lease renewals鈥攚hile the full text remains one click away. For anyone understanding Crown Castle SEC documents with AI, this page is the fastest path from filing to insight.
Savers Value Village, Inc. (SVV) 鈥� Form 144 filing
An affiliated seller (Mindy Geisser) intends to sell 7,824 common shares through Fidelity Brokerage on or about 04 Aug 2025 on the NYSE. At the cited market value of US$89.8k, the proposed sale equals roughly 0.005 % of the 155.6 m shares outstanding, so float impact is immaterial. The shares derive from an option granted 12 Jun 2019 and exercised 04 Aug 2025 for cash.
The same insider sold 52,176 shares during the last three months, realizing US$566.2k in gross proceeds (48,000 sh on 03 Jul 2025 and 4,176 sh on 01 Aug 2025). Under Rule 144 the filer attests to possessing no undisclosed adverse information and, if using a 10b5-1 plan, to compliance as of the adoption date.
Although the volume is modest relative to SVV鈥檚 float, the continuing pattern of insider disposals can influence sentiment and merits monitoring by investors tracking governance and trading activity.
Crown Castle Inc. (NYSE: CCI) filed a Form 8-K under Item 7.01 (Regulation FD) on 30 Jul 2025 to furnish鈥攏ot file鈥攁 press release announcing publication of its 2024 Sustainability Report and related updates to the company鈥檚 sustainability website. The press release is included as Exhibit 99.1; no financial statements or operational metrics accompany the filing.
The disclosure is strictly informational, aimed at investors focused on environmental, social and governance (ESG) issues. Because the furnished materials are excluded from Exchange Act liability and are not incorporated by reference into other SEC filings, the event carries no immediate accounting or guidance implications. There are no changes to executive leadership, capital structure, or earnings outlook disclosed.
Elevation Oncology (ELEV) filed five Post-Effective Amendments to prior Form S-8 registration statements to deregister all unsold shares tied to its 2019 Stock Incentive Plan, 2021 Equity Incentive Plan and 2021 ESPP. The move follows the 23 Jul 2025 closing of the merger with Concentra Biosciences, after which Elevation became a wholly owned subsidiary and its public offerings ceased.
Under the merger each common share was converted into $0.36 in cash plus one non-transferable contingent value right (CVR). Approximately 14.3 million shares鈥攁bout 9.7 m under the 2021 Plan, 1.7 m under the ESPP and 2.4 m under the 2019 Plan鈥攁re being withdrawn from registration. The filing removes any future equity issuance from these plans and formally ends the company鈥檚 S-8 reporting obligations.
FAQ
What is the current stock price of Crown Castle (CCI)?
What is the market cap of Crown Castle (CCI)?
What is Crown Castle's primary business?
How does Crown Castle generate revenue?
What makes Crown Castle's asset portfolio significant?
How does Crown Castle support wireless carrier operations?
What role does technology play in Crown Castle's operations?
What is Crown Castle's market position?
How does Crown Castle's business model benefit investors?
What are the core competitive advantages of Crown Castle?
